Literature DB >> 22419811

Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.

E Guzman1, C Cubillos-Zapata, M G Cottingham, S C Gilbert, H Prentice, B Charleston, J C Hope.   

Abstract

Dendritic cells (DC) are potent antigen-presenting cells and central to the induction of immune responses following infection or vaccination. The collection of DC migrating from peripheral tissues by cannulation of the afferent lymphatic vessels provides DC which can be used directly ex vivo without extensive in vitro manipulations. We have previously used bovine migrating DC to show that recombinant human adenovirus 5 vectors efficiently transduce afferent lymph migrating DEC-205(+) CD11c(+) CD8(-) DC (ALDC). We have also shown that recombinant modified vaccinia virus Ankara (MVA) infects ALDC in vitro, causing downregulation of costimulatory molecules, apoptosis, and cell death. We now show that in the bovine system, modified vaccinia virus Ankara-induced apoptosis in DC draining from the skin occurs soon after virus binding via the caspase 8 pathway and is not associated with viral gene expression. We also show that after virus entry, the caspase 9 pathway cascade is initiated. The magnitude of T cell responses to mycobacterial antigen 85A (Ag85A) expressed by recombinant MVA-infected ALDC is increased by blocking caspase-induced apoptosis. Apoptotic bodies generated by recombinant MVA (rMVA)-Ag85A-infected ALDC and containing Ag85A were phagocytosed by noninfected migrating ALDC expressing SIRPα via actin-dependent phagocytosis, and these ALDC in turn presented antigen. However, the addition of fresh ALDC to MVA-infected cultures did not improve on the magnitude of the T cell responses; in contrast, these noninfected DC showed downregulation of major histocompatibility complex class II (MHC-II), CD40, CD80, and CD86. We also observed that MVA-infected ALDC promoted migration of DEC-205(+) SIRPα(+) CD21(+) DC as well as CD4(+) and CD8(+) T cells independently of caspase activation. These in vitro studies show that induction of apoptosis in DC by MVA vectors is detrimental to the subsequent induction of T cell responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22419811      PMCID: PMC3347273          DOI: 10.1128/JVI.00264-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  83 in total

1.  Migratory sub-populations of afferent lymphatic dendritic cells differ in their interactions with Mycobacterium bovis Bacille Calmette Guerin.

Authors:  J C Hope; E Guzman; C Cubillos-Zapata; S A Stephens; S C Gilbert; H Prentice; P Sopp; C J Howard; B Charleston
Journal:  Vaccine       Date:  2012-01-24       Impact factor: 3.641

2.  Structural determinants of caspase-9 inhibition by the vaccinia virus protein, F1L.

Authors:  Eric Yu; Dayong Zhai; Chaofang Jin; Motti Gerlic; John C Reed; Robert Liddington
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

Review 3.  Lymphocyte homing and homeostasis.

Authors:  E C Butcher; L J Picker
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

4.  Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light.

Authors:  K Tsung; J H Yim; W Marti; R M Buller; J A Norton
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

5.  Summary of workshop findings for cattle (tables 1 and 2).

Authors:  C J Howard; J Naessens
Journal:  Vet Immunol Immunopathol       Date:  1993-11       Impact factor: 2.046

6.  Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.

Authors:  G A Colditz; T F Brewer; C S Berkey; M E Wilson; E Burdick; H V Fineberg; F Mosteller
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

7.  Bluetongue virus targets conventional dendritic cells in skin lymph.

Authors:  Behzad Hemati; Vanessa Contreras; Céline Urien; Michel Bonneau; Haru-Hisa Takamatsu; Peter P C Mertens; Emmanuel Bréard; Corinne Sailleau; Stéphan Zientara; Isabelle Schwartz-Cornil
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

8.  Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever.

Authors:  Birgit Schäfer; Georg W Holzer; Alexandra Joachimsthaler; Sogue Coulibaly; Michael Schwendinger; Brian A Crowe; Thomas R Kreil; P Noel Barrett; Falko G Falkner
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

9.  A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses.

Authors:  Juan García-Arriaza; José Luis Nájera; Carmen E Gómez; Nolawit Tewabe; Carlos Oscar S Sorzano; Thierry Calandra; Thierry Roger; Mariano Esteban
Journal:  PLoS One       Date:  2011-08-31       Impact factor: 3.240

10.  Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.

Authors:  F Sallusto; M Cella; C Danieli; A Lanzavecchia
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  18 in total

1.  Vaccinia Virus Encodes a Novel Inhibitor of Apoptosis That Associates with the Apoptosome.

Authors:  Melissa R Ryerson; Monique M Richards; Marc Kvansakul; Christine J Hawkins; Joanna L Shisler
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

2.  Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells.

Authors:  Nicola Ternette; Peter D Block; Álvaro Sánchez-Bernabéu; Nicola Borthwick; Elisa Pappalardo; Sultan Abdul-Jawad; Beatrice Ondondo; Philip D Charles; Lucy Dorrell; Benedikt M Kessler; Tomáš Hanke
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

3.  Germinal Center B Cell and T Follicular Helper Cell Responses to Viral Vector and Protein-in-Adjuvant Vaccines.

Authors:  Chuan Wang; Matthew Hart; Cecilia Chui; Augustine Ajuogu; Iona J Brian; Simone C de Cassan; Persephone Borrow; Simon J Draper; Alexander D Douglas
Journal:  J Immunol       Date:  2016-07-13       Impact factor: 5.422

Review 4.  Development of vaccines to Mycobacterium avium subsp. paratuberculosis infection.

Authors:  Hong-Tae Park; Han Sang Yoo
Journal:  Clin Exp Vaccine Res       Date:  2016-07-29

5.  Subset-Specific Expression of Toll-Like Receptors by Bovine Afferent Lymph Dendritic Cells.

Authors:  Dirk Werling; Jayne C Hope; Nazneen Siddiqui; Stephanie Widdison; Chris Russell; Paul Sopp; Tracey J Coffey
Journal:  Front Vet Sci       Date:  2017-04-03

6.  Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A.

Authors:  Magali Matsumiya; Elena Stylianou; Kristin Griffiths; Zoe Lang; Joel Meyer; Stephanie A Harris; Rosalind Rowland; Angela M Minassian; Ansar A Pathan; Helen Fletcher; Helen McShane
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

7.  Bovine γδ T cells are a major regulatory T cell subset.

Authors:  Efrain Guzman; Jayne Hope; Geraldine Taylor; Adrian L Smith; Carolina Cubillos-Zapata; Bryan Charleston
Journal:  J Immunol       Date:  2014-06-02       Impact factor: 5.422

8.  Immunity, safety and protection of an Adenovirus 5 prime--Modified Vaccinia virus Ankara boost subunit vaccine against Mycobacterium avium subspecies paratuberculosis infection in calves.

Authors:  Tim J Bull; Christina Vrettou; Richard Linedale; Catherine McGuinnes; Sam Strain; Jim McNair; Sarah C Gilbert; Jayne C Hope
Journal:  Vet Res       Date:  2014-10-29       Impact factor: 3.683

9.  Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection.

Authors:  Jarmila Knitlova; Vera Hajkova; Ludek Voska; Jana Elsterova; Barbora Obrova; Zora Melkova
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

10.  Transduction of skin-migrating dendritic cells by human adenovirus 5 occurs via an actin-dependent phagocytic pathway.

Authors:  Efrain Guzman; Geraldine Taylor; Jayne Hope; Rebecca Herbert; Carolina Cubillos-Zapata; Bryan Charleston
Journal:  J Gen Virol       Date:  2016-08-15       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.